- Home
- MRNA vs AU Comparison
MRNA vs AU Comparison
Compare MRNA & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- AU
- Stock Information
- Founded
- MRNA 2010
- AU 1944
- Country
- MRNA United States
- AU United States
- Employees
- MRNA N/A
- AU N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- AU Precious Metals
- Sector
- MRNA Health Care
- AU Basic Materials
- Exchange
- MRNA Nasdaq
- AU Nasdaq
- Market Cap
- MRNA 16.0B
- AU 17.9B
- IPO Year
- MRNA 2018
- AU 1972
- Fundamental
- Price
- MRNA $28.56
- AU $37.17
- Analyst Decision
- MRNA Hold
- AU Hold
- Analyst Count
- MRNA 20
- AU 5
- Target Price
- MRNA $54.82
- AU $34.00
- AVG Volume (30 Days)
- MRNA 9.3M
- AU 2.7M
- Earning Date
- MRNA 05-01-2025
- AU 05-06-2025
- Dividend Yield
- MRNA N/A
- AU 2.46%
- EPS Growth
- MRNA N/A
- AU N/A
- EPS
- MRNA N/A
- AU 2.33
- Revenue
- MRNA $3,236,000,000.00
- AU $5,793,000,000.00
- Revenue This Year
- MRNA N/A
- AU $37.67
- Revenue Next Year
- MRNA $23.65
- AU $1.47
- P/E Ratio
- MRNA N/A
- AU $15.87
- Revenue Growth
- MRNA N/A
- AU 26.43
- 52 Week Low
- MRNA $29.25
- AU $21.65
- 52 Week High
- MRNA $170.47
- AU $38.16
- Technical
- Relative Strength Index (RSI)
- MRNA 34.78
- AU 70.32
- Support Level
- MRNA $31.52
- AU $35.36
- Resistance Level
- MRNA $34.87
- AU $38.16
- Average True Range (ATR)
- MRNA 1.74
- AU 0.90
- MACD
- MRNA -0.37
- AU 0.27
- Stochastic Oscillator
- MRNA 15.53
- AU 86.22
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.